A detailed history of Srs Capital Advisors, Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 30 shares of ATRC stock, worth $921. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 38 21.05%
Holding current value
$921
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$20.34 - $29.5 $162 - $236
-8 Reduced 21.05%
30 $0
Q2 2024

Aug 06, 2024

BUY
$19.86 - $29.09 $675 - $989
34 Added 850.0%
38 $0
Q4 2023

Feb 06, 2024

SELL
$32.99 - $43.25 $626 - $821
-19 Reduced 82.61%
4 $0
Q3 2022

Nov 03, 2022

BUY
$38.25 - $52.62 $153 - $210
4 Added 21.05%
23 $1,000
Q4 2021

Feb 08, 2022

BUY
$63.4 - $87.14 $1,204 - $1,655
19 New
19 $1,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.43B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.